Ramsay Hunt syndrome type 1

From WikiMD's WELLNESSPEDIA


Ramsay Hunt syndrome type 1
Synonyms Dyssynergia cerebellaris myoclonica
Pronounce N/A
Specialty N/A
Symptoms Myoclonus, progressive ataxia, seizures
Complications N/A
Onset Typically in adulthood
Duration Chronic
Types N/A
Causes Genetic disorder
Risks Family history
Diagnosis Clinical diagnosis, genetic testing
Differential diagnosis Epilepsy, spinocerebellar ataxia
Prevention N/A
Treatment Anticonvulsant medications, physical therapy
Medication N/A
Prognosis Variable, depends on severity
Frequency Rare
Deaths N/A


Ramsay Hunt syndrome type 1 is a rare, neurological disorder characterized by myoclonus, ataxia, seizures, intellectual disability, and various neurological and psychiatric manifestations. It is also known as Dyssynergia Cerebellaris Myoclonica and Dyssynergia Cerebellaris Progressiva.

Symptoms[edit]

The symptoms of Ramsay Hunt syndrome type 1 typically begin in early adulthood and may include tremors, seizures, muscle weakness, and cognitive impairment. Other symptoms may include dysarthria (difficulty speaking), nystagmus (involuntary eye movement), and hypotonia (reduced muscle strength).

Causes[edit]

Ramsay Hunt syndrome type 1 is caused by a mutation in the ATP1A3 gene. This gene provides instructions for producing a protein that is involved in pumping ions across cell membranes. The mutation disrupts the function of the protein, leading to the symptoms of the disorder.

Diagnosis[edit]

Diagnosis of Ramsay Hunt syndrome type 1 is based on the clinical symptoms and confirmed by genetic testing. Magnetic resonance imaging (MRI) may also be used to detect changes in the brain associated with the disorder.

Treatment[edit]

Treatment for Ramsay Hunt syndrome type 1 is symptomatic and supportive. Medications may be used to manage seizures and myoclonus. Physical therapy may also be beneficial for managing ataxia and improving mobility.

Prognosis[edit]

The prognosis for individuals with Ramsay Hunt syndrome type 1 varies. Some individuals may have a relatively mild course with little progression while others may experience a rapid progression of symptoms and severe disability.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.